192 related articles for article (PubMed ID: 20564640)
1. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles.
Glazer ES; Curley SA
Cancer; 2010 Jul; 116(13):3285-93. PubMed ID: 20564640
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles.
Glazer ES; Massey KL; Zhu C; Curley SA
Surgery; 2010 Aug; 148(2):319-24. PubMed ID: 20541785
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Curley SA; Cherukuri P; Briggs K; Patra CR; Upton M; Dolson E; Mukherjee P
J Exp Ther Oncol; 2008; 7(4):313-26. PubMed ID: 19227011
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.
Glazer ES; Zhu C; Massey KL; Thompson CS; Kaluarachchi WD; Hamir AN; Curley SA
Clin Cancer Res; 2010 Dec; 16(23):5712-21. PubMed ID: 21138869
[TBL] [Abstract][Full Text] [Related]
5. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.
Cherukuri P; Curley SA
Methods Mol Biol; 2010; 624():359-73. PubMed ID: 20217608
[TBL] [Abstract][Full Text] [Related]
6. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.
Raoof M; Zhu C; Kaluarachchi WD; Curley SA
Int J Hyperthermia; 2012; 28(3):202-9. PubMed ID: 22515341
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
[TBL] [Abstract][Full Text] [Related]
8. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
Bhattacharyya S; Bhattacharya R; Curley S; McNiven MA; Mukherjee P
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14541-6. PubMed ID: 20679244
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
[TBL] [Abstract][Full Text] [Related]
11. Fe
Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
[TBL] [Abstract][Full Text] [Related]
12. The influence of cell and nanoparticle properties on heating and cell death in a radiofrequency field.
Mackeyev Y; Mark C; Kumar N; Serda RE
Acta Biomater; 2017 Apr; 53():619-630. PubMed ID: 28179157
[TBL] [Abstract][Full Text] [Related]
13. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effect Between Laser and Radiofrequency Heating of RGD-Gold Nanospheres on MCF7 Cell Viability.
Sánchez-Hernández L; Ferro-Flores G; Jiménez-Mancilla NP; Luna-Gutiérrez MA; Santos-Cuevas CL; Ocampo-García BE; Azorín-Vega E; Isaac-Olivé K
J Nanosci Nanotechnol; 2015 Dec; 15(12):9840-8. PubMed ID: 26682422
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy.
Male KB; Lachance B; Hrapovic S; Sunahara G; Luong JH
Anal Chem; 2008 Jul; 80(14):5487-93. PubMed ID: 18553941
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
Jung KH; Choe YS; Paik JY; Lee KH
J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
[TBL] [Abstract][Full Text] [Related]
18. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
19. Targeted imaging of EGFR overexpressed cancer cells by brightly fluorescent nanoparticles conjugated with cetuximab.
Gao M; Su H; Lin G; Li S; Yu X; Qin A; Zhao Z; Zhang Z; Tang BZ
Nanoscale; 2016 Aug; 8(32):15027-32. PubMed ID: 27468980
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery.
Melancon MP; Elliott AM; Shetty A; Huang Q; Stafford RJ; Li C
J Control Release; 2011 Dec; 156(2):265-72. PubMed ID: 21763373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]